<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for PCYC</title>
    <link />
    <description>Headlines for PHARMACYCLICS, INC.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Pharmacyclics Incorporated (PCYC): Today's Featured Drugs Winner</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11932940/1/pharmacyclics-incorporated-pcyc-todays-featured-drugs-winner.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 23 May 2013 17:00:00 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Raising The Drugs Industry Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11932614/1/5-stocks-raising-the-drugs-industry-higher.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 23 May 2013 13:03:00 GMT</pubDate>
    </item>
    <item>
      <title>FDA Designation for Synageva Candidate - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99954/fda-designation-for-synageva-candidate.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 22 May 2013 21:20:01 GMT</pubDate>
    </item>
    <item>
      <title>Tackling Cancer: Leukemia's Biggest Current and Upcoming Players</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/tackling-cancer-leukemias-biggest-current-upcoming/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 18:30:00 GMT</pubDate>
    </item>
    <item>
      <title>ASCO '13 Preview: Gilead's Big Cancer Debut</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11924167/1/asco-13-preview-gileads-big-cancer-debut.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 18:00:00 GMT</pubDate>
    </item>
    <item>
      <title>ASCO '13 Preview: Roche's Next-Gen Rituxan Steps Up</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11924149/1/asco-13-preview-roches-next-gen-rituxan-steps-up.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 18:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Pharmacyclics Rises On Unusually High Volume (PCYC)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11921885/1/pharmacyclics-rises-on-unusually-high-volume-pcyc.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 13 May 2013 15:53:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Biotech Stocks Spiking With Big Volume</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/3-biotech-stocks-spiking-big-volume.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 13 May 2013 14:41:00 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Top Upgrades</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/upgrades/13/05/3582633/benzingas-top-upgrades.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 13 May 2013 08:06:59 GMT</pubDate>
    </item>
    <item>
      <title>6 Superstars For Your Biotech Portfolio: John McCamant</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1424881-6-superstars-for-your-biotech-portfolio-john-mccamant.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 10 May 2013 14:57:16 GMT</pubDate>
    </item>
    <item>
      <title>Six Superstars for Your Biotech Portfolio: John McCamant</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/pcyc/articles/185861/six-superstars-for-your-biotech-portfolio-john-mccamant/2013-05-10.aspx?source=itxwebtxt0000015</link>
      <author>Trefis</author>
      <pubDate>Fri, 10 May 2013 09:34:36 GMT</pubDate>
    </item>
    <item>
      <title>Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1422381-cellceutix-corporation-the-next-generation-of-cancer-treatment-has-arrived.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 22:02:42 GMT</pubDate>
    </item>
    <item>
      <title>Amgen, Inc. (AMGN): Today's Most Compelling Stock Buy</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/amgen-inc-amgn-todays-most-compelling-stock-buy-cm244967.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Thu, 09 May 2013 12:55:48 GMT</pubDate>
    </item>
    <item>
      <title>A "Me Too" FDA Breakthrough</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/08/a-me-too-fda-breakthrough/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 08 May 2013 10:40:00 GMT</pubDate>
    </item>
    <item>
      <title>Pharmacyclics Inc. (PCYC): Today's Most Compelling Stock Buy</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/pharmacyclics-inc-pcyc-todays-most-compelling-stock-buy-cm244319.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 07 May 2013 13:53:41 GMT</pubDate>
    </item>
    <item>
      <title>Three Top Performing Healthcare Stocks to Watch</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/long-ideas/13/05/3562518/three-top-performing-healthcare-stocks-to-watch.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 06 May 2013 15:53:30 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1402281-biotech-watchlist-2013-update-exciting-ideas-have-explosive-potential.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 03 May 2013 22:18:32 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/clsn/articles/184614/biotech-watchlist-2013-update-exciting-ideas-have-explosive-potential/2013-05-03.aspx?source=itxwebtxt0000015</link>
      <author>Trefis</author>
      <pubDate>Fri, 03 May 2013 09:01:13 GMT</pubDate>
    </item>
    <item>
      <title>Wider-Than-Expected Loss at Pharmacyclics - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98488/wider-than-expected-loss-at-pharmacyclics.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 02 May 2013 14:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Pharmacyclics Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1392151-pharmacyclics-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 21:40:07 GMT</pubDate>
    </item>
  </channel>
</rss>
